GlassScriptPhysician profile
Nancy T Ngo
NPI 1366448557
$989.77
in general payments reported to CMS, 2019-2025
11 companies · $135 in 2025
The $135 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.72 · 2020: $147 · 2021: $313 · 2022: $149 · 2023: $106 · 2024: $126 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $422.59 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $175.79 | 2020-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Pfizer INC. | $151.79 | 2019-2025 | |
| Tris Pharma INC | $54.05 | 2021-2022 | |
| Sanofi Pasteur INC. | $53.32 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $30.93 | 2025 | Zoryve |
| Biomarin Pharmaceutical INC. | $26.81 | 2024 | Voxzogo 1.2mg |
| Ferring Pharmaceuticals INC. | $21.12 | 2025 | Adstiladrin |
| Corium, LLC | $20.61 | 2022 | |
| Ironshore Pharmaceuticals INC. | $18.44 | 2024 | |
| Supernus Pharmaceuticals, INC. | $14.32 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Ngo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.